CG
IBIO icon

Cutler Group’s iBio IBIO Stock Holding History

Cutler Group’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3
Closed -$1K – 5171
2022
Q2 		$1K Hold
3
– – ﹤0.01% 4610
2022
Q1 		$1K Sell
3
-18
-86% -$3.77K ﹤0.01% 4983
2021
Q4 		$7K Sell
21
-45
-68% -$17.2K ﹤0.01% 3956
2021
Q3 		$10K Sell
66
-15
-19% -$9.34K ﹤0.01% 3930
2021
Q2 		$11K Buy
81
+63
+350% +$46K ﹤0.01% 3812
2021
Q1 		$3K Sell
18
-13
-42% -$11.3K ﹤0.01% 4703
2020
Q4 		$4K Buy
31
+21
+210% +$17.1K ﹤0.01% 3787
2020
Q3 		$7K Buy
+10
New +$14.5K ﹤0.01% 3247

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APP
Avantax Planning Partners Dubuque, Iowa $4.02B AUM 20% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Cutler Group's IBIO Position: Q3 2023 in Review

Cutler Group sold out of iBio (IBIO) in Q3 2023, closing a stake of 10 shares.

Cutler Group first reported a position in IBIO in Q3 2020 and held it in 11 quarters. The position peaked at $9K in Q3 2021. 26 funds tracked by Wall St. Rank hold IBIO as of Q3 2023.

  • Cutler Group reported no remaining iBio position as of Q3 2023 after selling out during the quarter.
  • Cutler Group sold 10 iBio shares in Q3 2023.
  • Cutler Group first reported a position in iBio in Q3 2020 and held it in 11 quarters.
  • Cutler Group's iBio position peaked at $9K in Q3 2021.
  • 26 funds tracked by Wall St. Rank held iBio as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.